Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey (Q56944980)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey	article

Statements

scholarly article

0 references

Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

object named as

Eric J Topol

14

0 references

Paul W. Armstrong

object named as

Paul W Armstrong

20

0 references

Robert A Harrington

2

object named as

Robert A Harrington

0 references

13

object named as

Robert M Califf

0 references

Maarten L Simoons

7

object named as

Maarten L Simoons

0 references

Witold Rużyłło

16

object named as

Witold Ruzyllo

0 references

John H. Alexander

1

object named as

John H Alexander

0 references

Judith S Hochman

9

object named as

Judith S Hochman

0 references

10

object named as

Robert G Wilcox

0 references

4

object named as

Lisa G Berdan

0 references

6

object named as

Jaap W Deckers

0 references

A Michael Lincoff

5

object named as

A.Michael Lincoff

0 references

author name string

Robert H Tuttle

3

0 references

Alan Guerci

8

0 references

Michael M Kitt

11

0 references

Paul R Eisenberg

12

0 references

Karl Karsh

15

0 references

Janine Stepinska

17

0 references

Peter Widimsky

18

0 references

Jean B Boland

19

0 references

language of work or name

0 references

publication date

April 1999

0 references

American Journal of Cardiology

0 references

83

0 references

8

0 references

1147-1151

0 references

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Antiplatelet agents in the prevention and therapy of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Diagnosing and managing unstable angina. Agency for Health Care Policy and Research

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Development of aspirin resistance in persons with previous ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Sex differences in bleeding time and blood loss in normal subjects following aspirin ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Sex difference in antithrombotic effect of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of eryt

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Variations in Patient Management and Outcomes for Acute Myocardial Infarction in the United States and Other Countries

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Prospective Comparison of Patient Characteristics and Outcome of Non-prior Aspirin Users versus Aspirin Users with Unstable Angina or Non-Q-Wave Myocardial Infarction Treated with Combination Antithrombotic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Previous aspirin use may attenuate the severity of the manifestation of acute ischemic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Does aspirin consumption affect the presentation or severity of acute myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Clinical characteristics of nonfatal myocardial infarction among individuals on prophylactic low-dose aspirin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Unstable angina or non-Q wave infarction despite long-term aspirin: response to thrombolytic therapy with implications on mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Clinical and angiographic characteristics and outcome of patients with rest-unstable angina occurring during regular aspirin use.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Identifiers

10.1016/S0002-9149(99)00049-1

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56944980&oldid=1982955000"